433 related articles for article (PubMed ID: 33541430)
1. New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.
Choi JY; Choi CU; Choi BG; Park Y; Kang DO; Jang WY; Kim W; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Jeong MH; Chae SC; Seong IW; Yoon CH; Cha KS; Oh SK;
BMC Pharmacol Toxicol; 2021 Feb; 22(1):11. PubMed ID: 33541430
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction.
Choi JY; Choi CU; Hwang SY; Choi BG; Jang WY; Kim DY; Kim W; Park EJ; Lee S; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Chae SC; Kim YJ; Cho MC; Kim CJ; Kim HS; Jeong MH;
Am J Cardiol; 2018 Sep; 122(6):922-928. PubMed ID: 30217375
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over.
Kwak A; Kim JH; Choi CU; Kim IW; Oh JM; Kim K
Int J Clin Pharm; 2019 Apr; 41(2):460-469. PubMed ID: 30864086
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
[TBL] [Abstract][Full Text] [Related]
5. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.
Seo WW; Seo SI; Kim Y; Yoo JJ; Shin WG; Kim J; You SC; Park RW; Park YM; Kim KJ; Rhee SY; Park M; Jin ES; Kim SE
Cardiovasc Diabetol; 2022 May; 21(1):82. PubMed ID: 35606846
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
[TBL] [Abstract][Full Text] [Related]
7. Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
Giustino G; Colantonio LD; Brown TM; Carson AP; Dai Y; Farkouh ME; Monda KL; Muntner P; Rosenson RS
Cardiovasc Drugs Ther; 2018 Oct; 32(5):453-461. PubMed ID: 30078077
[TBL] [Abstract][Full Text] [Related]
8. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
[TBL] [Abstract][Full Text] [Related]
9. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
He W; Cao M; Li Z
Drug Dev Res; 2020 Aug; 81(5):551-556. PubMed ID: 32142170
[TBL] [Abstract][Full Text] [Related]
10. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
[TBL] [Abstract][Full Text] [Related]
11. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
[TBL] [Abstract][Full Text] [Related]
12. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg.
Stein B; Ward T; Hale G; Lyver E
Ann Pharmacother; 2020 May; 54(5):405-413. PubMed ID: 31718234
[No Abstract] [Full Text] [Related]
13. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
14. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
[TBL] [Abstract][Full Text] [Related]
15. Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study.
Lin JL; Chen PS; Lin HW; Tsai LM; Lin SH; Li YH
J Atheroscler Thromb; 2022 Aug; 29(8):1213-1225. PubMed ID: 34497171
[TBL] [Abstract][Full Text] [Related]
16. 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan's National Health Insurance Research Database.
Hsieh HC; Hsu JC; Lu CY
BMJ Open; 2017 May; 7(5):e014150. PubMed ID: 28515189
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence.
Perez-Calahorra S; Laclaustra M; Marco-Benedi V; Pinto X; Sanchez-Hernandez RM; Plana N; Ortega E; Fuentes F; Civeira F
Lipids Health Dis; 2019 Dec; 18(1):216. PubMed ID: 31829197
[TBL] [Abstract][Full Text] [Related]
18. Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 diabetes mellitus.
Bando Y; Toyama H; Kanehara H; Hisada A; Okafuji K; Toya D; Tanaka N
Diabetes Res Clin Pract; 2016 Jan; 111():66-73. PubMed ID: 26589368
[TBL] [Abstract][Full Text] [Related]
19. New onset diabetes mellitus and cardiovascular outcomes according to statin intensity in patients after drug-eluting stent implantation in Asian patients.
Chung J; Kim HL; Lim WH; Seo JB; Zo JH; Kim MA; Kim SH
Sci Rep; 2023 Sep; 13(1):16061. PubMed ID: 37749120
[TBL] [Abstract][Full Text] [Related]
20. Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes.
Park JY; Rha SW; Choi B; Choi JW; Ryu SK; Kim S; Noh YK; Choi SY; Akkala RG; Li H; Ali J; Xu S; Ngow HA; Lee JJ; Lee GN; Kim J; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim E; Park CG; SeogSeo H; Oh DJ
Int J Cardiol; 2015 Apr; 184():502-506. PubMed ID: 25756579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
